Skip to main content

SK Bioscience

SK Bioscience Co Ltd is a South Korean biopharmaceutical enterprise headquartered in Seongnam, South Korea. The company specializes in the research, development, contract manufacturing, and commercialization of vaccines and biological therapies. Its product line encompasses proprietary vaccines for influenza, chickenpox, and shingles alongside contract manufacturing services for international pharmaceutical partners. Revenue is generated from product sales of commercialized vaccines, manufacturing service contracts, and technology licensing fees. The enterprise targets public health agencies, clinical networks, and international pharmaceutical markets. SK Bioscience Co Ltd is publicly listed on the Korea Exchange.

4 of the funds FundTelligence covers report a position in SK Bioscience.

Legal name
SK Bioscience Co Ltd
Sector
Health Care
Country
South Korea
Funds holding it
4

Funds holding SK Bioscience

Loading...